IMNN ▲ +5.7% - Imunon, Inc. $IMNN - IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress Imunon shares rose 5.7% following the company's announcement of its 2026 R&D Day agenda and speakers, which will highlight clinical progress on IMNN-001, its lead candidate. The event typically provides investors with detailed updates on pipeline development and trial results, information that markets reward when a company signals meaningful advancement in its core programs. 09-SEP-2026 08:32 AM ET